Onderzoeker
Ahmed Atef Ahmed Abouzeid Mesalam
- Disciplines:Immunologie, Laboratoriumgeneeskunde
Affiliaties
- Vakgroep Klinische Biologie, Microbiologie en Immunologie (Departement)
Lid
Vanaf8 jan 2013 → 23 sep 2018
Publicaties
1 - 10 van 18
- Monoclonal antibodies as a new strategy for prevention and treatment of hepatitis C virus infection(2018)
Auteurs: Ahmed Atef Ahmed Abouzeid Mesalam
- A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo(2017)
Auteurs: Isabelle Desombere, Ahmed Atef Ahmed Abouzeid Mesalam, Richard A Urbanowicz, Zhen-Yong Keck, Aliasghar Farhoudi Moghadam, Koen Vercauteren, Karin Weening, Thomas F Baumert, Arvind H Patel, Steven KH Foung, et al.
Pagina's: 53 - 64 - Mouse systems to model hepatitis C virus treatment and associated resistance(2016)
Auteurs: Ahmed Atef Ahmed Abouzeid Mesalam, Koen Vercauteren
- Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice(2016)
Auteurs: Koen Vercauteren, Richard JP Brown, Ahmed Atef Ahmed Abouzeid Mesalam, Juliane Doerrbecker, Sabin Bhuju, Robert Geffers, Naomi Van den Eede, C Patrick McClure, Fulvia Troise, Thomas Baumert, et al.
Pagina's: 2029 - 2034 - Characterisation of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line(2016)
Auteurs: L Earnest-Silveira, B Chua, R Chin, D Christiansen, D Johnson, S Herrmann, SA Ralph, Koen Vercauteren, Ahmed Atef Ahmed Abouzeid Mesalam, S Das, et al.
Pagina's: 1865 - 1876 - A broadly neutralizing monoclonal antibody targeting hepatitis C virus prevents viral infection in vitro and in uPA/SCID mice with humanized liver(2015)
Auteurs: Ahmed Atef Ahmed Abouzeid Mesalam, Isabelle Desombere, Richard Urbanowicz, Daniel X Johansson, Aliasghar Farhoudi Moghadam, Freya Van Houtte, Lieven Verhoye, Mats Persson, Jonathan Ball, Geert Leroux-Roels, et al.
Aantal pagina's: 1 - Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice(2015)Volume: 62
Auteurs: Koen Vercauteren, Richard JP Brown, Ahmed Atef Ahmed Abouzeid Mesalam, Juliane Doerrbecker, Sabin Bhuju, Robert Geffers, Naomi Van den Eede, Fulvia Troise, Lieven Verhoye, Thomas Baumert, et al.
Pagina's: S214 - S214 - Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization(2014)
Auteurs: Koen Vercauteren, Ahmed Atef Ahmed Abouzeid Mesalam
Pagina's: 15975 - 15991 - Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents(2014)
Auteurs: Koen Vercauteren, Naomi Van den Eede, Ahmed Atef Ahmed Abouzeid Mesalam, Sandrine Belouzard, Maria Teresa Catanese, Dorothea Bankwitz, Flossie Wong-Staal, Riccardo Cortese, Jean Dubuisson, Charles M Rice, et al.
Pagina's: 1508 - 1518 - Characterization of a novel human monoclonal antibody targeting the hepatitis C virus envelope protein
Auteurs: Ahmed Atef Ahmed Abouzeid Mesalam, Isabelle Desombere, Richard Urbanowicz, Daniel X Johansson, Koen Vercauteren, Aliasghar Farhoudi Moghadam, Mats Persson, Jonathan Ball
Aantal pagina's: 1